VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
TDACW
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
TDACWTranslational Development Acquisition Corp.
$1.45$25M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksTDACWQuarterly Financials

Translational Development Acquisition Corp. (TDACW) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Translational Development Acquisition Corp. (TDACW) quarterly income statement — complete revenue, gross profit & net income history

TDACW Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q1'23Q2'22Q3'21Q2'21Q1'21Q4'20Q3'20Q2'20Q1'20Q4'19
Sales/Revenue--------------------
Revenue Growth %--------------------
Cost of Goods Sold--------------------
COGS % of Revenue--------------------
Gross Profit00000000000020.33M0000000
Gross Margin %------------63.03%-------
Gross Profit Growth %--------------------
Operating Expenses281.16K162.34K213.66K221.13K347.41K133.39K61.28K843843483.85K6021.7K5.21M734.67K703.09K-1.39K-532.73K-334.35K-262.56K-316.44K
OpEx % of Revenue------------16.14%-------
Selling, General & Admin281.16K162.34K213.66K221.13K347.41K133.39K61.28K843843483.85K6021.7K976.68K0000000
SG&A % of Revenue------------3.03%-------
Research & Development--------------------
R&D % of Revenue--------------------
Other Operating Expenses--------------------
Operating Income-281.16K-162.34K-213.66K-221.13K-347.41K-133.39K-61.28K-843-843-483.85K-602-1.7K-590.22K-734.67K-703.09K-1.39K-532.73K-334.35K-262.56K-316.44K
Operating Margin %-------------1.83%-------
Operating Income Growth %19.07%-21.71%-248.64%-26130.96%-41110.91%72.43%---40.03%----10.79%-119.73%-167.78%99.56%-118.33%-6.66%-16.07%-9.23%
EBITDA-281.16K-162.34K-213.66K-221.13K-347.41K-133.39K-61.28K00-483.85K00939.81K-2.79M150.92K215.84K-526.47K-255.85K-851.74M
EBITDA Margin %------------2.91%-------
EBITDA Growth %19.07%-21.71%-248.64%--72.43%------278.51%-992.12%177650.59%-87.61%-142.67%-111.04%-100%-15.63%
D&A (Non-Cash Add-back)000000084384306021.7K1.53M-2.06M854K217.23K6.27K78.5K262.48K2.06M
EBIT-281.16K-162.34K-213.66K-221.13K-347.41K-133.39K-61.28K-843-843-483.85K-602-1.7K14.94M-734.67K-703.09K-1.39K-532.73K-334.35K-262.56K1.74M
Net Interest Income001.87M000000000-3.79M9579331.18K6.27K78.5K262.48K0
Interest Income001.87M00000000009579331.18K6.27K78.5K262.48K1.51M
Interest Expense0000000000003.79M0000001.51M
Other Income/Expense--------------------
Pretax Income1.33M1.6M1.66M1.62M1.48M-8.04K-61.28K-843-843-483.85K-602-1.7K11.15M-2.79M150.92K-1.03K-526.47K-255.85K-85237.5K
Pretax Margin %------------34.58%-------
Income Tax0000000000000-79.22K-49.99K217.09K163.94K-22022050.04K
Effective Tax Rate %0%0%0%0%0%0%0%0%0%0%0%0%0%2.84%-33.13%-21158.48%-31.14%0.09%-258.82%21.07%
Net Income1.33M1.6M1.66M1.62M1.48M-8.04K-61.28K-843-843-483.85K-602-1.7K11.15M-2.71M200.91K-1.24K-690.4K-255.63K-305187.46K
Net Margin %------------34.58%-------
Net Income Growth %-10.13%19939.5%2808.94%192667.26%176028.11%98.34%---40.03%---1715.41%-962.07%65973.11%-100.66%-195.44%-130.89%-100.04%-73.5%
Net Income (Continuing)1.33M1.6M1.66M1.62M1.48M-8.04K-61.28K-843-843-483.85K-602-1.7K11.15M-2.71M200.91K-1.24K-690.4K-255.63K-305187.46K
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)0.060.070.080.070.37-0.00-0.02-0.00-0.00-0.12-0.00-0.001.55-0.380.03-0.00-0.10-0.040.000.03
EPS Growth %-83.57%-629.8%--98.75%------1711.23%-967.42%--100.76%-196.2%-129.67%-100.04%-78%
EPS (Basic)0.060.070.080.070.37-0.00-0.02-0.00-0.00-0.12-0.00-0.001.55-0.380.03-0.00-0.10-0.040.000.03
Diluted Shares Outstanding17.25M17.25M17.25M17.25M4.05M4.05M4.05M4.05M4.05M4.05M4.05M3.75M7.18M7.18M7.18M7.18M7.18M7.18M7.15M7.1M
Basic Shares Outstanding17.25M17.25M17.25M17.25M4.05M4.05M4.05M4.05M4.05M4.05M4.07M3.76M7.18M7.18M7.18M7.18M7.18M7.18M7.15M7.1M
Dividend Payout Ratio---113.62%----------------